Becton Dickinson says it has completed its $275 million acquisition of HandyLab, a specialist in molecular diagnostics. BD and HandyLab had begun an alliance earlier this year to combine BD’s GenOhm test with HandyLab’s Jaguar diagnostic. With the buy, BD gets ownership of the HandyLabs diagnostic platform, a hands-free operation that takes a test from sample preparation to detection. (Click here for more)
“BD Completes Acquisition Of HandyLab In $275 Million Transaction” – Business Journal (11/20/09)
JUST PUBLISHED: Medical Device Market 2009: Interventional Cardiology - Find out who’s going beyond catheters and drug-eluting stents in this vibrant space with this 86-page Special Report previously published in IN VIVO: The Business & Medicine Report. Order yours now!

